🗓Mark in your agenda one of the first top appointments of the first working day at the #JIMCongress2024!🚀 On March 21st, our coordinators Antonio Colombo and Giuseppe Tarantini MD, PhD will conduct 2️⃣ interesting LIVE CASEs focused on: CORONARY ARTERY DISEASE IN CHALLENGING SCENARIOS! 💥 Check below for the highlights!⤵️ #InterventionalCardiology
JIM Congress’ Post
More Relevant Posts
-
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. #FortreaAlwaysOn https://lnkd.in/ditmnABJ
-
-
Join us for our 12th annual #EchoFlorida on October 12-14 at Disney’s Grand Floridian Resort & Spa in Florida! 🧡 bit.ly/44zmtbI #EchoFlorida is a comprehensive review of echocardiography, featuring dedicated sessions on: - cardiomyopathies - coronary artery disease (including stress testing) - valvular heart disease - pericardial disease - heart failure - emerging technologies - complex congenital heart disease - 3D/4D echocardiography - strain imaging
-
-
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/e_GS-9B7
-
-
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/eMR3P57E
-
-
Passionate Life Sciences Leader | Fast-Tracking Treatments for Patients | Making a Positive Difference ❤️ | HBA Ambassador Champion | WEN (Women Empowerment Network) India Co-Lead
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/g6eWJThN
-
-
Strategic Transformation | 19 Patents | PSPO™ | PSM™ | LSSWB | LSSYB | LPLG | Microsoft Power BI Certified | Program And Project Management | Vendor Management | Operational Excellence| Data Analytics
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/dZ2bjF3P
-
-
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/dzgY8QyG
-
-
Inside Sales Manager-CRO-Changing the present;"Every great advance in science has issued from a new audacity of the imagination." John Dewey #fortreaforward #experiencematters
Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/gJx8BXrV
-
-
In a CHEST Physician® article from the Interstitial Lung Disease (ILD) Section, the authors highlight the growing interest in telomere length and its response to immunosuppression in the ILD community. Short telomere length is linked to rapid progression, worse outcomes, and poor response to immunosuppressants in idiopathic pulmonary fibrosis. Learn more about this connection: https://hubs.ly/Q02Hk3KS0
-
-
From cell type-specific studies to inflammatory bowel disease research, discover how we are making groundbreaking studies possible. Hear from some of our research partners on how we are supporting them deliver their research. https://lnkd.in/eAjKEijD #MedicalResearch #BioResource
